pH Dependent Uptake of Loperamide Across the Gastrointestinal Tract: An In Vitro Study

References

• Dajani E., Bianchi R., Bloss J., Adelstein G., East P. The pharmacology of SC‐27166: a novel antidiarrhoeal agent. J. Pharmacol. Exp. Ther. 1977; 203: 512–526
   PubMed Web of Science ®Google Scholar
• Mackerer C., Broughham L., East P., Bloss J., Dajani E., Clay G. Antidiarrhoeal and central nervous system activities of SC‐27166 (2‐[3‐5‐Methyl‐1,3,4‐Oxadiazol‐2‐YL)‐3,3‐Diphenylpropyl]‐2‐Azabicyclo[2.2.2]Octane), a new antidiarrhoeal agent, resulting from binding to opiate receptor sites of the brain and myenteric plexus. J. Pharmacol. Exp. Ther. 1977; 203: 527–538
   PubMed Web of Science ®Google Scholar
• Awouters F., Megens A., Verlinden M., Schuurkes J., Niemegeers C., Janssen P. Loperamide survey of studies on mechanism of its antidiarrhoeal activity. Dig. Dis. Sci. 1993; 38: 977–995
   PubMed Web of Science ®Google Scholar
• Dehaven‐Hudkins D., Cortes Burgos L., Cassel J., Daubert J., Dehaven R., Mansson E., Nagasaka H., Yu G., Yaksh T. Loperamide (ADL 2‐1294), an opioid antihyperalgesic agent with peripheral selectivity. J. Pharmacol. Exp. Ther. 1999; 289: 494–502, [CSA]
   PubMed Web of Science ®Google Scholar
• Tsuji A., Tamai I. Blood–brain barrier function of P‐glycoprotein. Adv. Drug Deliv. Rev. 1997; 25: 287–298, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Schinkel A. The physiological function of drug‐transporting P‐glycoproteins. Sem. Cancer Biol. 1997; 8: 161–170, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tsuji A., Tamai I. Carrier‐mediated intestinal transport of drugs. Pharm. Res. 1996; 13: 963–977, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ingels F., Augustijns P. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco‐2. J. Pharm. Sci. 2003; 92(8)1545–1558, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Crowe A., Wong P. Potential roles of P‐gp and calcium channels in loperamide and diphenoxylate transport. Toxicol. Appl. Pharmacol. 2003; 193: 127–137, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ooms L., Degryse A., Janssen P. Mechanism of action of loperamide. Scand. J. Gastroenterol., Suppl. 1984; 96: 145–155, [CSA]
   PubMedGoogle Scholar
• Schinkel A., Wagenaar E., Mol C., van Deemter L. P‐glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 1996; 97(11)2517–2524, [CSA]
   PubMed Web of Science ®Google Scholar
• Bailey C., Bryla P., Malick A. The use of the intestinal epithelial cell culture model, Caco‐2, in pharmaceutical development. Adv. Drug Deliv. Rev. 1996; 22: 85–103, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Hosoya K., Kim K., Lee V. Age‐dependent expression of P‐glycoprotein gp170 in Caco‐2 cell monolayers. Pharm. Res. 1996; 13: 885–890, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mizuuchi H., Katsura T., Ashida K., Hashimoto Y., Inui K. Diphenhydramine transport by pH‐dependent tertiary amine transport system in Caco‐2 cells. Am. J. Physiol.: Gasterointest. Liver Physiol. 2000; 278(4)G563–G569
   PubMed Web of Science ®Google Scholar
• Rubas W., Jezyk N., Grass G. Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell‐line (CACO‐2). J. Drug Target. 1995; 3: 15–21, [CSA]
   PubMed Web of Science ®Google Scholar
• Crowe A., Lemaire M. In vitro and in situ absorption of SDZ‐RAD using a human intestinal cell line (Caco‐2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm. Res. 1998; 15(11)1666–1672, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ambudkar S., Dey S., Hrycyna C., Ramachandra M., Pastan I., Gottesman M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 1999; 39: 361–398, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pannocchia A., Revelli S., Tamponi G., Giorgianni A., Todde R., Bosia A., Ghigo D. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells. Cell Biochem. Funct. 1996; 14: 11–18, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wandel C., Kim R., Wood M., Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P‐glycoprotein. Anesthesiology 2002; 96: 913–920, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dantzig A., Bergin L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco‐2. Biochim. Biophys. Acta 1990; 1027: 211–217
   PubMed Web of Science ®Google Scholar
• Thwaites D., Cavet M., Hirst B., Simmons N. Angiotensin‐converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco‐2) Cells. Br. J. Pharmacol. 1995; 114: 981–986, [CSA]
   PubMed Web of Science ®Google Scholar
• Walter E., Kissel T., Amidon G. The intestinal peptide carrier: a potential transport system for small peptide derived drugs. Adv. Drug Deliv. Rev. 1996; 20: 33–58, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Watson A., Levine S., Donowitz M., Montrose M. Kinetics and regulation of a polarized Na+ − H+ exchanger from Caco‐2 cells, a human intestinal cell line. Am. J. Physiol. 1991; 261: G229–G238
   PubMed Web of Science ®Google Scholar
• Dutt A., Heath L., Nelson J. P‐glycoprotein and organic cation secretion by the mammalian kidney. J. Pharmacol. Exp. Ther. 1994; 269: 1254–1260, [CSA]
   PubMed Web of Science ®Google Scholar
• Suzuki T., Oshimi M., Tomono K., Hanano M., Watanabe J. Investigation of transport mechanism of pentazocine across the blood–brain barrier using the in situ rat brain perfusion technique. J. Pharm. Sci. 2002; 91(11)2346–2353, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Emerich D., Snodgrass P., Pink M., Bloom F., Bartus R. Central analgesic actions of loperamide following transient permeation of the blood brain barrier with cereport (RMP‐7). Brain Res. 1998; 801: 259–266, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tayrouz Y., Ganssmann B., Ding R., Klingmann A., Aderjan R., Burhenne J., Haefeli W., Mikus G. Ritonavir increases loperamide plasma concentrations without evidence for P‐glycoprotein involvement. Clin. Pharmacol. Ther. 2001; 70(5)405–414, [CSA]
   PubMed Web of Science ®Google Scholar
• Litovitz T., Clancy C., Korberly B., Temple A., Mann K. Surveillance of loperamide ingestions: an analysis of 216 poison centre reports. Clin. Toxicol. 1997; 35: 11–19
   Web of Science ®Google Scholar
• McCowat L., Cutting W., Steinke D., McDonald T. Treating diarrhoea: children deserve special attention. Br. Med. J. 1997; 315: 1378–1379
   PubMed Web of Science ®Google Scholar
• Motala C., Hill I., Mann M., Bowie M. Effect of loperamide on stool output and duration of acute infectious diarrhoea in infants. J. Pediatr. 1990; 117: 467–471
   PubMed Web of Science ®Google Scholar
• Ericsson C., Johnson P. Safety and efficacy of loperamide. Am. J. Med. 1990; 88: 6A–10S, [CROSSREF]
   Google Scholar
• Sadeque A., Wandel C., He H., Shah S., Wood A. increased drug delivery to the brain by P‐glycoprotein inhibition. Clin. Pharmacol. Ther. 2000; 68: 231–237, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mizuuchi H., Katsura T., Hashimoto Y., Inui K. Transepithelial transport of diphenhydramine across monolayers of the human intestinal epithelial cell line Caco‐2. Pharm. Res. 2000; 17(5)539–545, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Karlsson J., Kuo S., Ziemniak J., Artursson P. Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein. Br. J. Pharmacol. 1993; 110: 1009–1016, [CSA]
   PubMed Web of Science ®Google Scholar
• Balkovetz D., Miyamoto Y., Tiruppathi C., Mahesh V., Leibach F., Ganapathy V. Inhibition of brush–border membrane Na+ − H+ exchanger by loperamide. J. Pharmacol. Exp. Ther. 1987; 243: 150–154, [CSA]
   PubMed Web of Science ®Google Scholar
• Collett A., Higgs N., Sims E., Rowland M., Warhurst G. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P‐glycoprotein in rat intestine and the human colonic cell line Caco‐2. J. Pharmacol. Exp. Ther. 1999; 288: 171–178, [CSA]
   PubMed Web of Science ®Google Scholar